Pacira stockholders approve 3.3M share increase in equity plan; director Gary Pace faces significant withhold vote

Pacira BioSciences, Inc.

Stockholders approved Amended 2011 Stock Incentive Plan, adding 3,300,000 new shares for future grants.
Gary Pace elected as Class III director with 16.1M for vs 23.9M withhold (40.3% support).
KPMG ratified as auditor for FY2023 with 41.9M votes for (99.3% of votes cast).
Advisory 'say-on-pay' vote approved with 34.6M for (86.5% of votes cast).
Plan approval vote: 24.1M for, 15.8M against (60.4% for, excluding broker non-votes).

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Pacira BioSciences, Inc. shareholders approved Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-13 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 2 — Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. For Against Abstain 41,872,540 282,024 12,746

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Pacira BioSciences, Inc. shareholders approved Advisory vote to approve the compensation of the Company's named executive officers at the 2023-06-13 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 3 — Advisory vote to approve the compensation of the Company’s named executive officers. For Against Abstain Broker Non-Votes 34,600,749 5,320,960 89,006 2,156,595

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Pacira BioSciences, Inc. shareholders approved Approval of the Company's Amended and Restated 2011 Stock Incentive Plan at the 2023-06-13 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 4 — Approval of the Company’s Amended and Restated 2011 Stock Incentive Plan. For Against Abstain Broker Non-Votes 24,138,558 15,817,929 54,228 2,156,595

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Pacira BioSciences, Inc. shareholders approved Election of three Class III directors to hold office until the 2026 Annual Meeting of Stockholders at the 2023-06-13 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-13

Exact text from the filing

Proposal 1 — Election of three Class III directors to hold office until the 2026 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified. Nominee: For Withhold Broker Non-Votes Christopher Christie 39,024,151 986,564 2,156,595 Gary Pace 16,140,036 23,870,679 2,156,595 David Stack 38,008,964 2,001,751 2,156,595

View on SEC.gov

Browse all shareholder votes →

Pacira BioSciences, Inc. filing history →

Source: SEC EDGAR

accession 0001396814-23-000029

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.